<http://mountaingroup.wpengine.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-bene-ts-patients-small-cell-lung-cancer/#article>
<http://schema.org/potentialAction>
_:ncf58ece8300248a5b25300d9ce495d59xb2
<https://mtngp.com/g1-therapeutics-announces-positive-trilaciclib-phase-2a-topline-data-showing-robust-myelopreservation-bene-ts-patients-small-cell-lung-cancer/>